COO logo

COO
Cooper Companies, Inc.

838
Mkt Cap
$11.92B
Volume
437,159.00
52W High
$89.83
52W Low
$60.00
PE Ratio
30.24
COO Fundamentals
Price
$59.95
Prev Close
$61.11
Open
$61.40
50D MA
$70.59
Beta
0.76
Avg. Volume
2.09M
EPS (Annual)
$1.87
P/B
1.43
Rev/Employee
$272,826.67
$16,655.20
Loading...
Loading...
News
all
press releases
10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up
TXG beats Q1 estimates as consumables growth, margin expansion and lower operating costs narrow losses year over year.
Zacks·1h ago
News Placeholder
More News
News Placeholder
PACB Q1 Earnings Beat, Revenues Miss Estimates, Gross Margin Down
PacBio beats Q1 earnings estimates as consumables growth and cost cuts offset flat revenue and a weaker gross margin.
Zacks·2h ago
News Placeholder
Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of +4.82% and +1.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1d ago
News Placeholder
Cooper Companies (NASDAQ:COO) Hits New 12-Month Low - Should You Sell?
Cooper Companies (NASDAQ:COO) Sets New 1-Year Low - What's Next...
MarketBeat·2d ago
News Placeholder
QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y
QuidelOrtho posts a wider Q1 loss as revenues fell 10.5% year over year, with weakness in respiratory testing pressuring margins and cash flow.
Zacks·2d ago
News Placeholder
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates
SOLV beats Q1 earnings and revenue estimates as growth in MedSurg, Dental and HIS offset sales decline and margin pressure.
Zacks·2d ago
News Placeholder
COO vs. SAUHY: Which Stock Is the Better Value Option?
COO vs. SAUHY: Which Stock Is the Better Value Option?
Zacks·2d ago
News Placeholder
Dentsply International (XRAY) Lags Q1 Earnings Estimates
Dentsply (XRAY) delivered earnings and revenue surprises of -3.95% and +5.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Can Sustained Product Momentum Drive BDX Stock Before Q2 Earnings?
BD rides on Medical and Interventional product momentum, but China dynamics and research funding could weigh on second-quarter fiscal 2026 results.
Zacks·4d ago
News Placeholder
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised
iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.
Zacks·4d ago
<
1
2
...
>

Latest COO News

View
Top Discussions